Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Moderna, Inc (NASDAQ:MRNA) gapped up 6.64% Friday morning after it was announced the company will join the S&P 500 beginning July 21. The pharmaceutical company, which created a COVID-19 vaccine, will replace Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN).
On Thursday morning, Jefferies increased its price target on Moderna to $250 and the stock blew through the level within the first 15 minutes of trading. Even if the stock drops down to fill the gap left behind on Friday, Moderna would still be about $10 higher than Jefferies target.
On Friday options traders were mixed on whether Moderna has room to fly higher in blue skies or if the gap up and run marked the temporary top although the traders skewed bullish. Bullish traders bet over $1.64 million Moderna’s stock hasn’t yet topped out yet while a number of bearish traders bet over $752,150 the stock will go south. The options trades below were filtered to include only orders totaling over $100,000.
See Also: COVID-19 Variants: What the Future Could Look Like After the Pandemic
Why It’s Important: When a sweep order occurs, it indicates the trader wanted to get into a position quickly and is anticipating an imminent large move in stock price. A sweeper pays market price for the call or put option instead of placing a bid, which sweeps the order book of multiple exchanges to fill the order immediately.
These types of option orders are usually made by institutions, and retail investors can find watching for sweepers useful because it indicates “smart money” has entered into a position.
The Bullish Moderna Trades: Below is a look at the notable options alerts, courtesy of Benzinga Pro:
The Bearish Moderna Trades: Below is a look at the notable options alerts.
MRNA Price Action: Moderna was trading up 9.5% to $284.47 at time of writing.